Table 1. An overall summary of the different treatments and results of all in vivo models that were applied in our study on the effect of Carbenoxolone on lung metastasis.
Model | Relevant processes in cancer formation | Dosage | Duration | Results |
---|---|---|---|---|
Subcutaneous Lung Model | Proliferation | 50 mg/kg every other day | 17 days | No significant difference |
Orthotropic Lung Model | Proliferation | 10 mg/kg every day | 17 days | No significant difference |
Tail Vein Injection – Lung Tumor Cell colonization | Adhesion Anoikis Colonization |
40 mg/kg every other day | 25 days | Treated group presented significantly lower number of lesions on lungs (p = 0.006) |
Tumor Resection Lung Metastasis Model | Adhesion Anoikis Colonization Intravasation Migration |
50 mg/kg every other day | 38 days | Treated group presented significantly lower number of lesions on lungs (p = 0.002) |